$65.50
0.14[0.21%]
At close: Apr 29
$65.50
0[0.00%]
After Hours: 4:00PM EDT
ANI Pharmaceuticals
(NASDAQ:ANIP)ANI Pharmaceuticals Stock (NASDAQ:ANIP), Insider Trading Activity
ANI Pharmaceuticals: Insider buying and selling updated today.
Insider Shares Owned
2.668M
Insider Percentage Owned
12.7%
Institutional Shares Held
8.752M
Institutional Percentage Held
41.7%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -27.232K | $65.10 | -$1.77M | SELL | -3.34% | 787.62K | Apr 18 - Apr 19 | View |
| Apr 17, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -22.768K | $65.91 | -$1.50M | SELL | -2.72% | 814.852K | Apr 15 - Apr 17 | View |
| Apr 15, 2024 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | -250 | $67.79 | -$16.95K | SELL | -0.42% | 59.731K | Apr 12 | View |
| Apr 02, 2024 | Chad Gassert | SVP - CORP. DEV. & STRATEGY | -20K | $67.25 | -$1.34M | SELL | -6.19% | 302.905K | Apr 01 | View |
| Mar 13, 2024 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | -250 | $66.54 | -$16.64K | SELL | -0.42% | 59.981K | Mar 13 | View |
| Mar 13, 2024 | Chad Gassert | SVP - CORP. DEV. & STRATEGY | -20K | $65.81 | -$1.32M | SELL | -5.83% | 322.905K | Mar 11 | View |
| Mar 11, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -10K | $67.17 | -$671.70K | SELL | -1.18% | 837.62K | Mar 08 | View |
| Mar 11, 2024 | Stephen P Carey | SVP & CFO | -12.003K | $65.96 | -$791.69K | SELL | -6.33% | 177.712K | Mar 07 - Mar 11 | View |
| Mar 08, 2024 | Nikhil Lalwani | PRESIDENT & CEO | -62.317K | $66.27 | -$4.13M | SELL | -13.15% | 411.629K | Mar 06 - Mar 08 | View |
| Mar 07, 2024 | James G Marken | SVP OPS & PROD DEV | -26.372K | $66.40 | -$1.75M | SELL | -17.72% | 122.458K | Mar 07 | View |
| Mar 07, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -40K | $65.77 | -$2.63M | SELL | -4.51% | 847.62K | Mar 05 - Mar 07 | View |
| Mar 06, 2024 | Christopher Mutz | HEAD OF RARE DISEASE | -5K | $66.00 | -$330.00K | SELL | -5.41% | 87.387K | Mar 05 | View |
| Mar 06, 2024 | Antonio R Pera | DIRECTOR | -7K | $65.20 | -$456.40K | SELL | -20.82% | 26.627K | Mar 04 | View |
| Feb 13, 2024 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | -250 | $56.04 | -$14.01K | SELL | -0.67% | 36.799K | Feb 13 | View |
| Jan 23, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -25.216K | $56.17 | -$1.42M | SELL | -2.76% | 887.62K | Jan 19 - Jan 23 | View |
| Jan 18, 2024 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -24.784K | $55.29 | -$1.37M | SELL | -2.64% | 912.836K | Jan 16 - Jan 18 | View |
| Jan 16, 2024 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | -250 | $56.43 | -$14.11K | SELL | -0.67% | 37.049K | Jan 12 | View |
| Dec 19, 2023 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | -50K | $52.55 | -$2.63M | SELL | -5.06% | 937.62K | Dec 15 - Dec 19 | View |
| Dec 11, 2023 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | -250 | $49.21 | -$12.30K | SELL | -0.67% | 37.299K | Dec 11 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.